France· FR:64281916
COMIRNATY JN.1 30 microgrammes/dose, dispersion injectable. Vaccin à ARNm contre la COVID-19
A medicinal product containing brétovaméran, registered in France by BIONTECH MANUFACTURING (ALLEMAGNE).
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- BRÉTOVAMÉRAN
- Manufacturer
- BIONTECH MANUFACTURING (ALLEMAGNE)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip13340093029976010 flacon(s) en verre multidose(s) de 6 dose(s)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Brétovaméran in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaCOMIRNATY JN.1BioNTech Manufacturing GmbH, Mainz
- NetherlandsComirnaty JN.1 10 microgram/dosis, concentraat voor dispersie voor injectieBioNTech Manufacturing GmbH
- FinlandComirnaty JN.1BioNTech Manufacturing GmbH
- SwedenComirnaty JN.1 (10 doser) 3 mikrogram/dos Koncentrat till injektionsvätska, dispersionBioNTech Manufacturing GmbH
- IrelandCOMIRNATY JN.1 10 micrograms/dose concentrate for dispersion for injection children 5 to 11 yearsBioNTech Manufacturing GmbH
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Comirnaty Jn.1
- Liechtenstein · Comirnaty Jn.1
- Norway · Comirnaty Jn.1
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f8f3de10-6127-4574-9eef-70984f2eef26 GET /v1/drugs/f8f3de10-6127-4574-9eef-70984f2eef26?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "64281916",
"date_amm": "2024-07-03",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/20/1528",
"substance": "BRÉTOVAMÉRAN",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "dispersion injectable",
"voies_administration": "intramusculaire",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Oui"
}See everything about brétovaméran.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.